These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10563762)

  • 21. Development of a human epidermal growth factor derivative with EGFR-blocking and depleted biological activities: A comparative in vitro study using EGFR-positive breast cancer cells.
    Mehrabi M; Mansouri K; Soleymani B; Hoseinkhani Z; Shahlaie M; Khodarahmi R
    Int J Biol Macromol; 2017 Oct; 103():275-285. PubMed ID: 28501600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of chemical modification on the pharmacokinetics and biodistribution of carboxymethyl dextran as a drug carrier.
    Lee SD; Lim SJ; Kim CK
    Drug Deliv; 2002; 9(3):187-93. PubMed ID: 12396736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a Widely Usable Amino Acid Tracer: ⁷⁶Br-α-Methyl-Phenylalanine for Tumor PET Imaging.
    Hanaoka H; Ohshima Y; Suzuki Y; Yamaguchi A; Watanabe S; Uehara T; Nagamori S; Kanai Y; Ishioka NS; Tsushima Y; Endo K; Arano Y
    J Nucl Med; 2015 May; 56(5):791-7. PubMed ID: 25814518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of high-performance liquid chromatography in the isolation and characterisation of mouse and rat epidermal growth factors and examination of apparent heterogeneity.
    Smith JA; Ham J; Winslow DP; O'Hare MJ; Rudland PS
    J Chromatogr; 1984 Feb; 305(2):295-308. PubMed ID: 6323502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urinary transforming growth factors in neoplasia: separation of 125I-labeled transforming growth factor-alpha from epidermal growth factor in human urine.
    Stromberg K; Hudgins WR
    Cancer Res; 1986 Nov; 46(11):6004-10. PubMed ID: 3019543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and in vitro studies of epidermal growth factor-dextran conjugates for boron neutron capture therapy.
    Gedda L; Olsson P; Pontén J; Carlsson J
    Bioconjug Chem; 1996; 7(5):584-91. PubMed ID: 8889021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Production of mouse epidermal growth factor in yeast: high-level secretion using Pichia pastoris strains containing multiple gene copies.
    Clare JJ; Romanos MA; Rayment FB; Rowedder JE; Smith MA; Payne MM; Sreekrishna K; Henwood CA
    Gene; 1991 Sep; 105(2):205-12. PubMed ID: 1937016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of disulfide bonds in the structure and function of murine epidermal growth factor (mEGF).
    Alewood D; Nielsen K; Alewood PF; Craik DJ; Andrews P; Nerrie M; White S; Domagala T; Walker F; Rothacker J; Burgess AW; Nice EC
    Growth Factors; 2005 Jun; 23(2):97-110. PubMed ID: 16019431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural and dynamical comparison of alpha, beta and gamma forms of murine epidermal growth factor.
    Mayo KH; Burke C
    Eur J Biochem; 1987 Nov; 169(1):201-7. PubMed ID: 3500044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolism of epidermal growth factor receptor targeting probe [11C]PD153035: impact on biodistribution and tumor uptake in rats.
    Samén E; Arnberg F; Lu L; Olofsson MH; Tegnebratt T; Thorell JO; Holmin S; Stone-Elander S
    J Nucl Med; 2013 Oct; 54(10):1804-11. PubMed ID: 24003078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application to a cartilage targeting strategy: synthesis and in vivo biodistribution of (14)C-labeled quaternary ammonium-glucosamine conjugates.
    Giraud I; Rapp M; Maurizis JC; Madelmont JC
    Bioconjug Chem; 2000; 11(2):212-8. PubMed ID: 10725098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of epidermal growth factor signaling: regulation of steroid biosynthesis and the steroidogenic acute regulatory protein in mouse Leydig tumor cells.
    Manna PR; Huhtaniemi IT; Wang XJ; Eubank DW; Stocco DM
    Biol Reprod; 2002 Nov; 67(5):1393-404. PubMed ID: 12390868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolism of i.v. administered 45 kDa epidermal growth factor in the rat.
    Jørgensen PE; Nexø E; Raaberg L; Rasmussen TN; Poulsen SS
    Regul Pept; 1990 Sep; 30(2):113-23. PubMed ID: 2274677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. General method to label antisense oligonucleotides with radioactive halogens for pharmacological and imaging studies.
    Kühnast B; Dollé F; Terrazzino S; Rousseau B; Loc'h C; Vaufrey F; Hinnen F; Doignon I; Pillon F; David C; Crouzel C; Tavitian B
    Bioconjug Chem; 2000; 11(5):627-36. PubMed ID: 10995205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Positron emission tomography of experimental melanoma with.
    Mårs U; Tolmachev V; Sundin A
    Nucl Med Biol; 2000 Nov; 27(8):845-9. PubMed ID: 11150719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tissue distribution of 111In-labeled uricase conjugated with charged dextrans and polyethylene glycol.
    Fujita T; Yasuda Y; Takakura Y; Hashida M; Sezaki H
    J Pharmacobiodyn; 1991 Nov; 14(11):623-9. PubMed ID: 1725532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The in vitro characterization and biostability of 99mTc-dextran and its accumulation within the inflamed paws of adjuvant-induced arthritic rats.
    Kellaway IW; Seale L; Spencer PS
    Pharm Res; 1995 Apr; 12(4):588-93. PubMed ID: 7541134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Human positron emission tomography with oral 11C-vinpocetine].
    Vas A; Christer H; Sóvágó J; Johan S; Cselényi Z; Kiss B; Kárpáti E; Lars F; Gulyás B
    Orv Hetil; 2003 Nov; 144(46):2271-6. PubMed ID: 14702922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and preliminary evaluation of 18F-labeled pyridaben analogues for myocardial perfusion imaging with PET.
    Mou T; Zhao Z; Fang W; Peng C; Guo F; Liu B; Ma Y; Zhang X
    J Nucl Med; 2012 Mar; 53(3):472-9. PubMed ID: 22302832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on the metabolism of the novel antitumor agent [N-methyl-11C]N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in rats and humans prior to phase I clinical trials.
    Osman S; Luthra SK; Brady F; Hume SP; Brown G; Harte RJ; Matthews JC; Denny WA; Baguley BC; Jones T; Price PM
    Cancer Res; 1997 Jun; 57(11):2172-80. PubMed ID: 9187117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.